CeloNova BioSciences, Inc., headquartered in San Antonio, Texas, is a global medical device company that develops, manufactures and markets a family of Interventional Cardiology and Endovascular products. Our products are developed and manufactured in California, U.S.A. and Germany. The Company’s regional offices are located in Germany, France, United Kingdom, Netherlands and Austria. CeloNova’s Interventional Cardiology and Endovascular products are currently available in more than fifty countries.
News & Media
New technical and clinical possibilities in transarterial embolization of liver tumors: bland and microsphere-enhanced chemoembolization.